Sandi Kwee to Choline
This is a "connection" page, showing publications Sandi Kwee has written about Choline.
Connection Strength
7.273
-
Kwee SA, Tiirikainen M, Sato MM, Acoba JD, Wei R, Jia W, Le Marchand L, Wong LL. Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma. Cancer Res. 2019 04 01; 79(7):1696-1704.
Score: 0.638
-
Kwee SA, Wong L, Chan OTM, Kalathil S, Tsai N. PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology. 2018 04; 287(1):294-302.
Score: 0.592
-
Kwee SA, Lim J, Coel MN. Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride: A Possible Abscopal Effect? Clin Nucl Med. 2017 Nov; 42(11):868-871.
Score: 0.584
-
Kwee SA, Sato MM, Kuang Y, Franke A, Custer L, Miyazaki K, Wong LL. [18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling. Mol Imaging Biol. 2017 06; 19(3):446-455.
Score: 0.567
-
Lee J, Sato MM, Coel MN, Lee KH, Kwee SA. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT. J Nucl Med. 2016 07; 57(7):1058-64.
Score: 0.519
-
Kwee SA, Lim J, Watanabe A, Kromer-Baker K, Coel MN. Prognosis Related to Metastatic Burden Measured by ?8F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer. J Nucl Med. 2014 Jun; 55(6):905-10.
Score: 0.455
-
Kwee SA, Coel MN, Lim J. Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging. Ann Nucl Med. 2012 Jul; 26(6):501-7.
Score: 0.399
-
Kwee S, Song MA, Cheng I, Loo L, Tiirikainen M. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clin Transl Sci. 2012 Feb; 5(1):65-70.
Score: 0.394
-
Kwee S, Ernst T. Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET. Mol Imaging Biol. 2010 Aug; 12(4):424-5; author reply 426.
Score: 0.353
-
Kwee SA, Coel MN. Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT. Clin Nucl Med. 2010 Feb; 35(2):128-9.
Score: 0.341
-
Kwee SA, Coel MN, Ly BH, Lim J. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer. Ann Nucl Med. 2009 Aug; 23(6):541-8.
Score: 0.327
-
Kwee SA, DeGrado T. Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels. Eur J Nucl Med Mol Imaging. 2008 Aug; 35(8):1567-9; author reply 1570.
Score: 0.308
-
Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging. 2008 Jan-Feb; 7(1):12-20.
Score: 0.295
-
Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007 Nov; 37(6):420-8.
Score: 0.292
-
Kwee SA, Ko JP, Jiang CS, Watters MR, Coel MN. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology. 2007 Aug; 244(2):557-65.
Score: 0.285
-
Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006 Feb; 47(2):262-9.
Score: 0.259
-
Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005 Jan; 173(1):252-5.
Score: 0.240
-
Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004 Jul; 14(3):285-9.
Score: 0.232
-
Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1017-25.
Score: 0.122
-
DeGrado TR, Kwee SA, Coel MN, Coleman RE. The impact of urinary excretion of (18)F-labeled choline analogs. J Nucl Med. 2007 Jul; 48(7):1225.
Score: 0.071